180 related articles for article (PubMed ID: 35073918)
1. Biomimetic manganese-eumelanin nanocomposites for combined hyperthermia-immunotherapy against prostate cancer.
Liu Y; Shang W; Liu H; Hui H; Wu J; Zhang W; Gao P; Guo K; Guo Y; Tian J
J Nanobiotechnology; 2022 Jan; 20(1):48. PubMed ID: 35073918
[TBL] [Abstract][Full Text] [Related]
2. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
[TBL] [Abstract][Full Text] [Related]
3. CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin.
Jang Y; Cho YS; Kim A; Zhou X; Kim Y; Wan Z; Moon JJ; Park H
ACS Appl Mater Interfaces; 2024 Apr; 16(14):17129-17144. PubMed ID: 38533538
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
5. Tumor microcalcification-mediated relay drug delivery for photodynamic immunotherapy of breast cancer.
Jian H; Wang X; Song P; Wu X; Zheng R; Wang Y; Zhang H
Acta Biomater; 2022 Mar; 140():518-529. PubMed ID: 34923096
[TBL] [Abstract][Full Text] [Related]
6. Intrinsically Bioactive Manganese-Eumelanin Nanocomposites Mediated Antioxidation and Anti-Neuroinflammation for Targeted Theranostics of Traumatic Brain Injury.
Sun D; Liu K; Li Y; Xie T; Zhang M; Liu Y; Tong H; Guo Y; Zhang Q; Liu H; Fang J; Chen X
Adv Healthc Mater; 2022 Aug; 11(16):e2200517. PubMed ID: 35695187
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of Fe
Zhang Y; Liu S; Li D; He C; Wang D; Wei M; Zheng S; Li J
Colloids Surf B Biointerfaces; 2023 Sep; 229():113452. PubMed ID: 37474429
[TBL] [Abstract][Full Text] [Related]
8. Modulation of tumor microenvironment using a TLR-7/8 agonist-loaded nanoparticle system that exerts low-temperature hyperthermia and immunotherapy for in situ cancer vaccination.
Chen PM; Pan WY; Wu CY; Yeh CY; Korupalli C; Luo PK; Chou CJ; Chia WT; Sung HW
Biomaterials; 2020 Feb; 230():119629. PubMed ID: 31767446
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable mesoporous nanocomposites with dual-targeting function for enhanced anti-tumor therapy.
Gao S; Liu Y; Liu M; Yang D; Zhang M; Shi K
J Control Release; 2022 Jan; 341():383-398. PubMed ID: 34863841
[TBL] [Abstract][Full Text] [Related]
10. A Biomimetic Polymer Magnetic Nanocarrier Polarizing Tumor-Associated Macrophages for Potentiating Immunotherapy.
Liu L; Wang Y; Guo X; Zhao J; Zhou S
Small; 2020 Sep; 16(38):e2003543. PubMed ID: 32812355
[TBL] [Abstract][Full Text] [Related]
11. Multivalent Carbohydrate Nanocomposites for Tumor Microenvironment Remodeling to Enhance Antitumor Immunity.
Hyun GH; Jeong DH; Yang YY; Cho IH; Ha YJ; Xing X; Abbott DW; Hsieh YSY; Kang YP; Cha JH; Hong SS; Lee SJ; Kim YS; Kwon SW
ACS Nano; 2023 Jun; 17(12):11567-11582. PubMed ID: 37306074
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species / photothermal therapy dual-triggered biomimetic gold nanocages nanoplatform for combination cancer therapy via ferroptosis and tumor-associated macrophage repolarization mechanism.
Wei Y; Wang Z; Yang J; Xu R; Deng H; Ma S; Fang T; Zhang J; Shen Q
J Colloid Interface Sci; 2022 Jan; 606(Pt 2):1950-1965. PubMed ID: 34695762
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic Nanoparticles Carrying a Repolarization Agent of Tumor-Associated Macrophages for Remodeling of the Inflammatory Microenvironment Following Photothermal Therapy.
Yue Y; Li F; Li Y; Wang Y; Guo X; Cheng Z; Li N; Ma X; Nie G; Zhao X
ACS Nano; 2021 Sep; 15(9):15166-15179. PubMed ID: 34469109
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional silica nanocomposites prime tumoricidal immunity for efficient cancer immunotherapy.
Yang L; Li F; Cao Y; Liu Q; Jing G; Niu J; Sun F; Qian Y; Wang S; Li A
J Nanobiotechnology; 2021 Oct; 19(1):328. PubMed ID: 34663354
[TBL] [Abstract][Full Text] [Related]
15. M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.
Choo YW; Kang M; Kim HY; Han J; Kang S; Lee JR; Jeong GJ; Kwon SP; Song SY; Go S; Jung M; Hong J; Kim BS
ACS Nano; 2018 Sep; 12(9):8977-8993. PubMed ID: 30133260
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy.
Chen M; Shen Y; Pu Y; Zhou B; Bing J; Ge M; Zhu Y; Gao S; Wu W; Zhou M; Shi J
Biomaterials; 2023 Dec; 303():122386. PubMed ID: 37977008
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic 2D layered double hydroxide nanocomposites for hyperthermia-facilitated homologous targeting cancer photo-chemotherapy.
Wang J; Sun L; Liu J; Sun B; Li L; Xu ZP
J Nanobiotechnology; 2021 Oct; 19(1):351. PubMed ID: 34717639
[TBL] [Abstract][Full Text] [Related]
18. An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer
Cheng Y; Chen Q; Guo Z; Li M; Yang X; Wan G; Chen H; Zhang Q; Wang Y
ACS Nano; 2020 Nov; 14(11):15161-15181. PubMed ID: 33143424
[TBL] [Abstract][Full Text] [Related]
19. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Cellular Ablation by Attenuating Hypoxia Status and Reprogramming Tumor-Associated Macrophages via NIR Light-Responsive Upconversion Nanocrystals.
Ai X; Hu M; Wang Z; Lyu L; Zhang W; Li J; Yang H; Lin J; Xing B
Bioconjug Chem; 2018 Apr; 29(4):928-938. PubMed ID: 29466856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
